Article
September 9, 2024
Mucke, director of the Gladstone Institute of Neurological Disease, discusses what's next for Alzheimer’s research, the role of nonprofit research in developing new therapies, and why he's more hopeful than ever for a future where neurodegenerative diseases are fully treatable—and even preventable.
Alzheimer’s Disease
Neurological Disease
Mucke Lab
Aging
Gladstone in the News
June 12, 2024
The Voice of San Francisco—Gladstone President Deepak Srivastava, MD, talks about technologies driving the next wave of medicine, the importance of philanthropy dollars in fueling scientific breakthroughs, and how biotech is still breathing life into San Francisco's Mission Bay neighborhood.
Philanthropy
Srivastava Lab
Aging
AI
CRISPR/Gene Editing
Stem Cells/iPSCs
Article
April 24, 2017
Gladstone scientists identify inflammatory pathways as a potential therapeutic target for frontotemporal dementia
Gan Lab
Aging
Immunology
Article
March 24, 2016
Chris Carrico talks about Gladstone’s sense of connection and his excitement in studying poorly understood diseases.
Aging
HIV/AIDS
Article
January 26, 2016
How much you eat can influence your genes and affect how you age. Eric Verdin is researching ways to replicate this epigenetic trick with a drug.
Aging
Article
December 2, 2015
John Harris challenged the Gladstone community in a discussion about prolonging the human lifespan.
People Services
Aging
Diversity
